Report Detail

Pharma & Healthcare Global Anti-Camelid VHH Antibody Market Growth (Status and Outlook) 2022-2028

  • RnM4490254
  • |
  • 09 September, 2022
  • |
  • Global
  • |
  • 89 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Anti-Camelid VHH Antibody is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Anti-Camelid VHH Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Anti-Camelid VHH Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Anti-Camelid VHH Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Anti-Camelid VHH Antibody market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Anti-Camelid VHH Antibody players cover Genscript Biotech Corporation, Rockland Immunochemicals, Inc., ABclonal, Eurogentec and Jackson ImmunoResearch, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Anti-Camelid VHH Antibody market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Anti-Camelid VHH Antibody market, with both quantitative and qualitative data, to help readers understand how the Anti-Camelid VHH Antibody market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Anti-Camelid VHH Antibody market and forecasts the market size by Type (Western Blot and ELISA,), by Application (Cell and Gene Therapy, Genetic Diagnosis and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Western Blot
ELISA

Segmentation by application
Cell and Gene Therapy
Genetic Diagnosis
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Genscript Biotech Corporation
Rockland Immunochemicals, Inc.
ABclonal
Eurogentec
Jackson ImmunoResearch
Southern Biotech
LSBio
Stratech

Chapter Introduction
Chapter 1: Scope of Anti-Camelid VHH Antibody, Research Methodology, etc.
Chapter 2: Executive Summary, global Anti-Camelid VHH Antibody market size and CAGR, Anti-Camelid VHH Antibody market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Anti-Camelid VHH Antibody revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Anti-Camelid VHH Antibody revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Anti-Camelid VHH Antibody market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Genscript Biotech Corporation, Rockland Immunochemicals, Inc., ABclonal, Eurogentec, Jackson ImmunoResearch, Southern Biotech, LSBio and Stratech, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Anti-Camelid VHH Antibody Market Size 2017-2028
    • 2.1.2 Anti-Camelid VHH Antibody Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Anti-Camelid VHH Antibody Segment by Type
    • 2.2.1 Western Blot
    • 2.2.2 ELISA
  • 2.3 Anti-Camelid VHH Antibody Market Size by Type
    • 2.3.1 Anti-Camelid VHH Antibody Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Anti-Camelid VHH Antibody Market Size Market Share by Type (2017-2022)
  • 2.4 Anti-Camelid VHH Antibody Segment by Application
    • 2.4.1 Cell and Gene Therapy
    • 2.4.2 Genetic Diagnosis
    • 2.4.3 Others
  • 2.5 Anti-Camelid VHH Antibody Market Size by Application
    • 2.5.1 Anti-Camelid VHH Antibody Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Anti-Camelid VHH Antibody Market Size Market Share by Application (2017-2022)

3 Anti-Camelid VHH Antibody Market Size by Player

  • 3.1 Anti-Camelid VHH Antibody Market Size Market Share by Players
    • 3.1.1 Global Anti-Camelid VHH Antibody Revenue by Players (2020-2022)
    • 3.1.2 Global Anti-Camelid VHH Antibody Revenue Market Share by Players (2020-2022)
  • 3.2 Global Anti-Camelid VHH Antibody Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Anti-Camelid VHH Antibody by Regions

  • 4.1 Anti-Camelid VHH Antibody Market Size by Regions (2017-2022)
  • 4.2 Americas Anti-Camelid VHH Antibody Market Size Growth (2017-2022)
  • 4.3 APAC Anti-Camelid VHH Antibody Market Size Growth (2017-2022)
  • 4.4 Europe Anti-Camelid VHH Antibody Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Anti-Camelid VHH Antibody Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Anti-Camelid VHH Antibody Market Size by Country (2017-2022)
  • 5.2 Americas Anti-Camelid VHH Antibody Market Size by Type (2017-2022)
  • 5.3 Americas Anti-Camelid VHH Antibody Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Anti-Camelid VHH Antibody Market Size by Region (2017-2022)
  • 6.2 APAC Anti-Camelid VHH Antibody Market Size by Type (2017-2022)
  • 6.3 APAC Anti-Camelid VHH Antibody Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Anti-Camelid VHH Antibody by Country (2017-2022)
  • 7.2 Europe Anti-Camelid VHH Antibody Market Size by Type (2017-2022)
  • 7.3 Europe Anti-Camelid VHH Antibody Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Anti-Camelid VHH Antibody by Region (2017-2022)
  • 8.2 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Anti-Camelid VHH Antibody Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Anti-Camelid VHH Antibody Market Forecast

  • 10.1 Global Anti-Camelid VHH Antibody Forecast by Regions (2023-2028)
    • 10.1.1 Global Anti-Camelid VHH Antibody Forecast by Regions (2023-2028)
    • 10.1.2 Americas Anti-Camelid VHH Antibody Forecast
    • 10.1.3 APAC Anti-Camelid VHH Antibody Forecast
    • 10.1.4 Europe Anti-Camelid VHH Antibody Forecast
    • 10.1.5 Middle East & Africa Anti-Camelid VHH Antibody Forecast
  • 10.2 Americas Anti-Camelid VHH Antibody Forecast by Country (2023-2028)
    • 10.2.1 United States Anti-Camelid VHH Antibody Market Forecast
    • 10.2.2 Canada Anti-Camelid VHH Antibody Market Forecast
    • 10.2.3 Mexico Anti-Camelid VHH Antibody Market Forecast
    • 10.2.4 Brazil Anti-Camelid VHH Antibody Market Forecast
  • 10.3 APAC Anti-Camelid VHH Antibody Forecast by Region (2023-2028)
    • 10.3.1 China Anti-Camelid VHH Antibody Market Forecast
    • 10.3.2 Japan Anti-Camelid VHH Antibody Market Forecast
    • 10.3.3 Korea Anti-Camelid VHH Antibody Market Forecast
    • 10.3.4 Southeast Asia Anti-Camelid VHH Antibody Market Forecast
    • 10.3.5 India Anti-Camelid VHH Antibody Market Forecast
    • 10.3.6 Australia Anti-Camelid VHH Antibody Market Forecast
  • 10.4 Europe Anti-Camelid VHH Antibody Forecast by Country (2023-2028)
    • 10.4.1 Germany Anti-Camelid VHH Antibody Market Forecast
    • 10.4.2 France Anti-Camelid VHH Antibody Market Forecast
    • 10.4.3 UK Anti-Camelid VHH Antibody Market Forecast
    • 10.4.4 Italy Anti-Camelid VHH Antibody Market Forecast
    • 10.4.5 Russia Anti-Camelid VHH Antibody Market Forecast
  • 10.5 Middle East & Africa Anti-Camelid VHH Antibody Forecast by Region (2023-2028)
    • 10.5.1 Egypt Anti-Camelid VHH Antibody Market Forecast
    • 10.5.2 South Africa Anti-Camelid VHH Antibody Market Forecast
    • 10.5.3 Israel Anti-Camelid VHH Antibody Market Forecast
    • 10.5.4 Turkey Anti-Camelid VHH Antibody Market Forecast
    • 10.5.5 GCC Countries Anti-Camelid VHH Antibody Market Forecast
  • 10.6 Global Anti-Camelid VHH Antibody Forecast by Type (2023-2028)
  • 10.7 Global Anti-Camelid VHH Antibody Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Genscript Biotech Corporation
    • 11.1.1 Genscript Biotech Corporation Company Information
    • 11.1.2 Genscript Biotech Corporation Anti-Camelid VHH Antibody Product Offered
    • 11.1.3 Genscript Biotech Corporation Anti-Camelid VHH Antibody Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Genscript Biotech Corporation Main Business Overview
    • 11.1.5 Genscript Biotech Corporation Latest Developments
  • 11.2 Rockland Immunochemicals, Inc.
    • 11.2.1 Rockland Immunochemicals, Inc. Company Information
    • 11.2.2 Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Product Offered
    • 11.2.3 Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Rockland Immunochemicals, Inc. Main Business Overview
    • 11.2.5 Rockland Immunochemicals, Inc. Latest Developments
  • 11.3 ABclonal
    • 11.3.1 ABclonal Company Information
    • 11.3.2 ABclonal Anti-Camelid VHH Antibody Product Offered
    • 11.3.3 ABclonal Anti-Camelid VHH Antibody Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 ABclonal Main Business Overview
    • 11.3.5 ABclonal Latest Developments
  • 11.4 Eurogentec
    • 11.4.1 Eurogentec Company Information
    • 11.4.2 Eurogentec Anti-Camelid VHH Antibody Product Offered
    • 11.4.3 Eurogentec Anti-Camelid VHH Antibody Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Eurogentec Main Business Overview
    • 11.4.5 Eurogentec Latest Developments
  • 11.5 Jackson ImmunoResearch
    • 11.5.1 Jackson ImmunoResearch Company Information
    • 11.5.2 Jackson ImmunoResearch Anti-Camelid VHH Antibody Product Offered
    • 11.5.3 Jackson ImmunoResearch Anti-Camelid VHH Antibody Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Jackson ImmunoResearch Main Business Overview
    • 11.5.5 Jackson ImmunoResearch Latest Developments
  • 11.6 Southern Biotech
    • 11.6.1 Southern Biotech Company Information
    • 11.6.2 Southern Biotech Anti-Camelid VHH Antibody Product Offered
    • 11.6.3 Southern Biotech Anti-Camelid VHH Antibody Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Southern Biotech Main Business Overview
    • 11.6.5 Southern Biotech Latest Developments
  • 11.7 LSBio
    • 11.7.1 LSBio Company Information
    • 11.7.2 LSBio Anti-Camelid VHH Antibody Product Offered
    • 11.7.3 LSBio Anti-Camelid VHH Antibody Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 LSBio Main Business Overview
    • 11.7.5 LSBio Latest Developments
  • 11.8 Stratech
    • 11.8.1 Stratech Company Information
    • 11.8.2 Stratech Anti-Camelid VHH Antibody Product Offered
    • 11.8.3 Stratech Anti-Camelid VHH Antibody Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Stratech Main Business Overview
    • 11.8.5 Stratech Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Anti-Camelid VHH Antibody. Industry analysis & Market Report on Anti-Camelid VHH Antibody is a syndicated market report, published as Global Anti-Camelid VHH Antibody Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Anti-Camelid VHH Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,286.68
6,573.36
3,733.20
7,466.40
530,151.00
1,060,302.00
298,692.60
597,385.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report